Acarix A/S (ACARIX) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.442x

Based on the latest financial reports, Acarix A/S (ACARIX) has a cash flow conversion efficiency ratio of -0.442x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-16.89 Million ≈ $-1.82 Million USD) by net assets (Skr38.17 Million ≈ $4.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ACARIX defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Acarix A/S - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Acarix A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Acarix A/S Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Acarix A/S ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Projektengagemang Sweden AB (publ)
ST:PENG-B
0.038x
Kingsmen Resources Ltd
V:KNG
-0.052x
Datron AG
XETRA:DAR
-0.017x
Klondike Gold Corp
V:KG
-0.008x
Latch Inc
NASDAQ:LTCH
-0.134x
Yao I Fabric Co Ltd
TWO:4430
0.002x
Mestron Holdings
KLSE:0207
0.233x
Buyung Poetra Sembada Tbk PT
JK:HOKI
0.209x

Annual Cash Flow Conversion Efficiency for Acarix A/S (2014–2025)

The table below shows the annual cash flow conversion efficiency of Acarix A/S from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see ACARIX market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr38.17 Million
≈ $4.11 Million
Skr-48.38 Million
≈ $-5.21 Million
-1.268x -51.52%
2024-12-31 Skr75.70 Million
≈ $8.15 Million
Skr-63.33 Million
≈ $-6.81 Million
-0.837x +46.65%
2023-12-31 Skr51.88 Million
≈ $5.58 Million
Skr-81.37 Million
≈ $-8.76 Million
-1.568x -8.55%
2022-12-31 Skr51.83 Million
≈ $5.58 Million
Skr-74.87 Million
≈ $-8.06 Million
-1.445x -202.56%
2021-12-31 Skr100.54 Million
≈ $10.82 Million
Skr-48.01 Million
≈ $-5.17 Million
-0.477x -6.90%
2020-12-31 Skr82.14 Million
≈ $8.84 Million
Skr-36.69 Million
≈ $-3.95 Million
-0.447x +23.17%
2019-12-31 Skr76.60 Million
≈ $8.24 Million
Skr-44.53 Million
≈ $-4.79 Million
-0.581x -32.32%
2018-12-31 Skr87.88 Million
≈ $9.46 Million
Skr-38.61 Million
≈ $-4.15 Million
-0.439x -39.74%
2017-12-31 Skr128.94 Million
≈ $13.88 Million
Skr-40.54 Million
≈ $-4.36 Million
-0.314x -439.92%
2016-12-31 Skr155.52 Million
≈ $16.74 Million
Skr-9.06 Million
≈ $-974.57K
-0.058x +91.81%
2015-12-31 Skr12.14 Million
≈ $1.31 Million
Skr-8.63 Million
≈ $-928.83K
-0.711x +48.48%
2014-12-31 Skr15.12 Million
≈ $1.63 Million
Skr-20.87 Million
≈ $-2.25 Million
-1.380x --

About Acarix A/S

ST:ACARIX Sweden Medical Devices
Market Cap
$31.21 Million
Skr290.01 Million SEK
Market Cap Rank
#23678 Global
#460 in Sweden
Share Price
Skr0.25
Change (1 day)
-1.19%
52-Week Range
Skr0.24 - Skr0.43
All Time High
Skr20.62
About

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauri… Read more